Company
United StatesBiomarin Pharmaceuticals Inc, Brisbane, CA – FDA Inspections
Inspection records and compliance data for Biomarin Pharmaceuticals Inc in Brisbane, CA. 1 FDA inspection on record, 1 Form 483, last inspected December 06, 2016.
Company Profile
This profile covers Biomarin Pharmaceuticals Inc based in Brisbane, CA, United States.
FDA Inspection History
- FDA inspections
- 1
- OAI
- 0
- VAI
- 0
- NAI
- 0
- Unclassified
- 1
- Form 483s
- 1
- Warning letters
- 0
Inspected December 6, 2016.
Most cited issue areas
- Failure to develop written procedures1 inspection
- Late submission of 15-day report1 inspection
FDA inspections (1)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| December 6, 2016 | Not classified | Human Drugs · Postmarket Surv. and Epidemiology | 1000920 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Biomarin Pharmaceuticals Inc
FEI Number
3012821201
Address
2000 Sierra Point Pkwy Ste 600, Brisbane, CA 94005-1851, United States
Country
United States
ID: bd1063c9-0493-4e38-a9d5-d9a69d5f1531